Mammothix

Mammothix

Innovative AI-driven solutions for mammography, enhancing early detection and diagnostic accuracy. Learn more

Launch date
Employees
Company register number 1388601332
Seoul South Korea (HQ)

  • Edit
DateInvestorsAmountRound

N/A

Seed
*

N/A

Acquisition
N/A

N/A

Seed
Total Funding-

Recent News about Mammothix

Edit
More about Mammothixinfo icon
Edit

Mammo6 operates in the healthcare technology sector, specializing in artificial intelligence (AI) solutions for mammography. The company focuses on enhancing early detection and diagnostic accuracy of breast cancer through advanced AI algorithms. Their primary clients include hospitals, diagnostic centers, and healthcare providers who aim to improve patient outcomes and streamline diagnostic processes. Mammo6's business model revolves around a subscription-based service, where clients pay for access to their AI-driven diagnostic tools and software. Revenue is generated through these subscriptions, as well as through partnerships and collaborations with healthcare institutions. The company operates in a highly specialized market, leveraging cutting-edge technology to address critical needs in breast cancer detection and diagnosis.

Keywords: AI, mammography, breast cancer, early detection, diagnostic accuracy, healthcare technology, subscription-based, hospitals, diagnostic centers, patient outcomes.